Generalizability of a prediction rule for sick leave due to shoulder pain by Kuijpers, A.C. et al.
440	 Scand	J	Work	Environ	Health	2007,	vol	33,	no	6
Original article
Scand	J	Work	Environ	Health	2007;33(6):440–446
Generalizability of a prediction rule for sick leave due to shoulder pain
by Ton Kuijpers, PhD,1, 2, 3 Yvonne Vergouwe, PhD,4 Geert JMG van der Heijden, PhD,4 Sandra DM Bot, 
PhD,1 Jos WR Twisk, PhD,1, 5 Daniëlle AWM van der Windt, PhD,1, 6 Lex M Bouter, PhD 1
Kuijpers T, Vergouwe Y, van der Heijden GJMG, Bot SDM, Twisk JWR, van der Windt DAWM, Bouter LM. Generaliz-
ability of a prediction rule for sick leave due to shoulder pain. Scand J Work Environ Health. 2007;33(6):440–446.
Objectives   Recently, a rule was developed to predict sick leave related to shoulder pain during a period of 6 
months after patients have consulted a general practitioner for a new episode of shoulder pain. The objective was 
to evaluate the generalizability of this prediction rule by testing it in two other populations of workers who had 
gone for a consultation in primary care for a new episode of shoulder pain. 
Methods   The prediction rule was derived in a prognostic cohort study (N=350). The outcome was sick leave 
related to shoulder pain during 6 months following the first consultation. The rule was tested on merged control 
groups from three trials on shoulder pain (N=128). In addition to this population, a recently conducted study on 
musculoskeletal disorders (N=224) was used to validate the prediction rule. The generalizability of the prediction 
rule was tested by studying calibration and discrimination in the validation cohorts.
Results   The prediction rule showed reasonable calibration in both validation cohorts. The discriminative ability, 
with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.70 in the derivation cohort was 
stable in the cohort of the musculoskeletal disorder study (AUC 0.71). In the control groups of the three random-
ized controlled trials of a Dutch shoulder study, the discriminative ability decreased to an AUC of 0.66. 
Conclusions   The prediction rule for sick leave related to shoulder pain in a 6-month period following the first 
consultation in primary care showed adequate generalizability to another population of workers with shoulder 
pain participating in an observational cohort study. In the control groups of the three randomized controlled trials 
the prediction rule performed less well.
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Shoulder pain is common, with a 1-year prevalence 
ranging between 5% and 47% (1–7). In occupational 
settings, the 1-year prevalence ranges between 16% and 
47% (3–5). A Finnish study (8) reported a 1-year inci-
dence of 14% for shoulder pain among forestry work-
ers. Shoulder pain has an unfavorable outcome in many 
patients. About 40% to 50% of all patients who go for 
a consultation in primary care due to a new episode of 
shoulder pain report persistent pain and disability after 
6 to 12 months (9–11). 
The early identification (risk stratification) of pa-
tients with a high risk of sick leave due to shoulder pain 
may enable timely intervention and prevent sick leave 
and the concomitant high costs these patients generate. 
We developed a clinical prediction rule consisting of 
the following four easily measurable prognostic fac-
tors: sick leave at baseline in the preceding 2 months 
(0/0–1/≥1 weeks), shoulder pain (0–10), strain or over-
use due to usual activities as a precipitating cause (yes, 
no), and concomitant psychological complaints (yes, no) 
(table 1). Points are given for each of the four prognostic 
factors, and a total score is calculated. 
The total score corresponds with the estimated risk 
for sick leave due to shoulder pain during the 6 months 
following a first consultation for patients with a new epi-
sode of shoulder pain in primary care. The performance 
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(ie, calibration and discrimination) of the prediction 
rule was evaluated in the development study (12). Cali-
bration refers to the extent to which the observed fre-
quencies agree with the predicted probabilities of sick 
leave. Discrimination refers to the ability to distinguish 
between a patient with a high risk for sick leave and a 
patient who will not have to stay off work because of 
shoulder pain. 
Before the implementation of the prediction rule 
in clinical practice was considered, its generalizability 
needed to be tested (13–15). Generalizability refers 
to the performance of patients drawn from a different 
but comparable population (13). Our objective was 
to evaluate the performance of our clinical prediction 
rule for sick leave due to shoulder pain in two different 
cohorts of patients with shoulder pain in a primary care 
setting. 
Study population and methods
In this study, we evaluated the generalizability of the 
derived prediction rule from a Dutch shoulder study in 
a subgroup of other patients from this cohort and among 
participants of another prospective cohort study in general 
practice, the musculoskeletal disorder study (MDS). 
Dutch shoulder study
The Dutch shoulder study (DSS) was a comprehensive 
cohort study carried out between January 2000 and May 
2005. It consisted of one prognostic cohort study and 
three randomized controlled trials, which were carried 
out in parallel (see figure 1). Between January 2001 and 
June 2003, 103 general practitioners recruited patients 
at their first consultation for a new episode of shoulder 
complaints in three geographic areas in the Netherlands 
(Amsterdam, Groningen, and Maastricht). 
All of the patients in the Dutch shoulder study had 
to meet the following general inclusion criteria: was 18 
years of age or older; had paid work; had not consulted 
a general practitioner or received any form of treatment 
for the afflicted shoulder in the preceding 3 months; and 
had sufficient knowledge of the Dutch language. 
The patients had to meet the specific additional in-
clusion criteria of the trial in which they were included, 
if eligible, as follows: dysfunction of the cervicothoracic 
spine and adjacent ribs with accompanying pain or re-
stricted movement in the Groningen manipulation study, 
>3-month duration of symptoms in the graded exercise 
therapy study, and <3-month duration of symptoms in 
the education and activation program.
In both the Dutch shoulder study and the musculo-
skeletal disorder study, those with severe physical or 
psychological conditions (ie, fractures or dislocation in 
the shoulder region, rheumatic disease, neoplasm, neuro-
logical or vascular disorders, dementia) were excluded. 
For the prognostic cohort study, no additional inclusion 
criteria were specified. Data from the prognostic cohort 
study were used to derive the prediction rule. Data from 
the control groups of the three trials were used to study 
the generalizability of the rule. For the current study 
only the patients who reported paid work were used.
The Groningen manipulation study (16–17) evalu-
ated the effectiveness of manipulative therapy for the 
shoulder girdle in addition to usual care. In the two other 
trials, graded exercise therapy (18) and an education 
and activation program (19) were used. The participants 
Table 1. Prognostic score chart for predicting sick leave during 6 months following a first consultation. The predicted probability of sick 
leave during 6 months was determined by P=1/[1+ exp – (–1.72 + 0.53 × sick leave 0–1 week + 0.77 × sick leave >1 week + 0.50 × shoul-
der pain (4–6 points) + 0.65 × shoulder pain (7–10 points) + 0.68 × overuse due to usual activities + 1.38 × concomitant psychological 
problems)].a
    Total score Risk (%)
Sick leave in the preceding 2 months
 None 0 … ≤1 10–20
 0–1 week 2 … 2–3 20–30
 >1 week 3 … 4–5 30–40
Intensity of shoulder pain (0–10)   6–7 40–50
 0–3 points 0 … 8 50–60
 4–6 points 2 … 9–10 60–70
 7–10 points 3 … 11–12 70–80
Perceived cause: strain or overuse during regular activities 3 … 13–15 80–90
Reported psychological problems (anxiety, distress, depression) 6 …  +  
         
Total score  …  
a Instruction: If a predictor is scored positively, the given weight needs to be filled in. Subsequently the scores are added to calculate the “total score”. With 
the use of the table next to the score chart, the risk (%) of sick leave for an individual patient can be determined on the basis of the total score.
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were evenly allocated to the treatment groups on the 
basis of a random list prepared by an independent statis-
tician not involved in recruiting the patients. A research 
assistant opened preprepared, numbered, opaque enve-
lopes, which were sealed and contained the treatment 
allocation codes (16–19). The patients in the control 
groups of the trials received usual care, similar to that 
of the patients in the cohort study. 
Baseline and follow-up assessments for all of the 
patients were identical in the Dutch shoulder study. The 
outcome was measured with the use of postal question-
naires at 6 weeks, 3 months, and 6 months.
Musculoskeletal disorder study
The musculoskeletal disorder study (MDS) is a large 
observational cohort study that was conducted in 61 
general practices (97 general practitioners) (20–21). 
The physicians recruited patients who consulted them 
due to a new episode of musculoskeletal pain. For our 
generalizability study, we selected patients who came for 
a consultation for shoulder pain and who had paid work 
at baseline. The selection criteria were comparable with 
those of the Dutch shoulder study. Follow-up question-
naires were sent after 3, 6, and 12 months. 
Prediction rule
The rule predicted sick leave due to shoulder pain (yes 
= ≥1 day, no = 0 days) during 6 months after the first 
consultation with a physician about shoulder pain and 
was developed using information from the 350 patients 
of the derivation cohort who reported paid work at base-
line. Sociodemographic variables, disease characteristics 
(ie, pain intensity, disability, duration of complaints, 
sick leave in the 2 months prior to the consultation, 
onset, comorbidity), physical workload, work-related 
psychosocial factors, psychological factors, and results 
of a physical examination were documented. The ques-
tionnaire also included a general single-item question 
regarding the presence (yes, no) of any psychologi-
cal problems (eg, distress, depression, anxiety). These 
factors were used to compose a prognostic model and 
derive the prediction rule. We tested the internal valid-
ity with bootstrapping techniques and corrected the 
prediction rule for overoptimism (13). The calibration 
of the prediction rule was adequate. The discriminative 
ability was satisfactory with an area under the receiver 
operating characteristic (ROC) curve of 0.70 [95% con-
fidence interval (95% CI) 0.64–0.76]. In table 1 on page 
441 the prediction rule is presented as a score chart. The 
Patients with shoulder pain in the 
catchment area, consulting their GP
Eligible for participation in local RCT?
Participant local RCT
Eligible for participation in the cohort?
Yes
No data collection
No
Randomization
Yes
Allocated to a control group?
Usual care according to national guidelines
(Similar data collection at baseline and at 1, 3, and 6 months)
Validation cohort Derivation cohort
Yes
No
Figure 1. Design of the Dutch shoulder study.  
(GP = general practitioner, RCT = randomized 
controlled trial)
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 development of this score chart and prediction rule has 
been described in detail elsewhere (12).
Analysis
The performance of the prediction rule was tested in 
the validation cohorts by evaluating its calibration and 
discrimination. Calibration was assessed by plotting the 
predicted probabilities of sick leave according to the 
prediction rule, against the observed frequencies. For 
this process, the patients were grouped into quintiles ac-
cording to their predicted probability of sick leave. The 
prevalence of the end point within each quintile equaled 
the observed frequency. 
The area under the ROC curve was used to assess the 
discriminative ability of the prediction rule. An area un-
der the curve (AUC) of 0.5 indicated no discrimination 
above chance, whereas an AUC of 1.0 indicated perfect 
discrimination. Since the discriminative ability of a rule 
is related to the homogeneity of the sample in which the 
rule is applied, we also estimated the maximum AUC 
attainable for the validation cohorts. With the use of the 
predicted risks of the patients in the validation cohorts, 
outcomes were generated with Monte Carlo simulation 
(22–23). The simulation mimics a situation in which the 
model is perfectly calibrated, thereby showing the extent 
to which poor calibration can affect the discriminative 
performance of the model. The AUC that is subsequently 
estimated for the predicted risks and generated outcomes 
is considered the maximum attainable AUC for the vali-
dation sample.
Furthermore, to gain insight into the performance 
of our prediction rule, we estimated the multivariable 
logistic regression coefficients for each of the predic-
tors of our prediction rule in the validation cohorts. This 
analysis showed which of the different elements of the 
rule were the strongest predictors of sick leave in the 
validation cohorts.
Results
Study population
Table 2 presents the baseline characteristics of the 
derivation cohort and validation cohorts. The patients in 
the DSS control groups clearly showed a longer dura-
tion of complaints at baseline (>3 months: 51% versus 
38%) and reported 10% more concomitant low-back 
pain in comparison with the derivation cohort. Patients 
in the musculoskeletal disorder study were less often 
male (42% versus 55%), more often reported strain or 
overuse due to usual activities as a precipitating cause 
Table 2. Description of the baseline characteristics of the workers with shoulder pain in the derivation and validation cohorts. (DSS= Dutch 
shoulder study, MDS = musculoskeletal disorder study, SD= standard deviation, IQR = interquartile range)
 Derivation cohort Validation cohort
 DSS (N=350) DSS controls (N=128) MDS (N=224)
 N % Mean SD N % Mean SD N % Mean SD
Demographic characteristics            
 Age (years) 45 11 · · 46 9 · · 44 10 · ·
 Gender (male) 193 55 · · 63 50 · · 95 42 · ·
Disease characteristics            
 Duration of complaints >3 months 134 38 · · 65 51 · · 90 40 · ·
 Sick leave at baseline in preceding 2 months a            
  0 weeks 254 74 · · 98 78 · · 149 67 · ·
  ≤1 weeks 44 13 · · 8 6 · · 30 13 · ·
  >1 weeks 46 13 · · 20 16 · · 45 20 · ·
 Precipitating cause            
  Strain or overuse, usual activities a 99 28 · · 40 31 · · 104 46 · ·
 Shoulder complaints in the past 199 57 · · 79 62 · · 114 50 · ·
 Concomitant psychological complaints a 27 8 · · 10 8 · · 37 17 · ·
 Concomitant musculoskeletal complaints            
  Neck or high back-pain 119 34 · · 51 40 · · 128 58 · ·
  Low-back pain 61 17 · · 34 27 · · 77 34 · ·
 Shoulder pain (0–10) a · · 4.5 2.3 · · 5.2 2.3 · · 4.9 2.2
Work-related psychosocial factors b            
 Quantitative job demands (4–20) · · 12.8 2.7 · · 12.6 2.6 · · 13.1 3.2
 Decision authority (3–12) · · 9.4 1.8 · · 9.6 1.9 · · 9.1 2.1
 Co-worker support (4–16) · · 12.3 2.0 · · 12.3 1.9 · · 12.3 1.7
a Variables that are in the rule predicting sick leave due to shoulder pain.
b A score between 10 and 15 points reflects fair quantitative job demands; a score of >9 points reflects high decision authority; a score of >12 points re-
flects high co-worker support.
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(46% versus 28%), and more often reported concomitant 
musculoskeletal complaints of the neck or high back 
(58% versus 34%) and low back (34% versus 17%). The 
patients in the derivation and validation cohorts reported 
similar percentages of sick leave for the first 6 months 
after the first consultation (30% for the DSS derivation 
cohort, 34% for the DSS control groups, and 32% for the 
MDS cohort).
In the MDS cohort, 90% of all of the patients com-
pleted the 6-month questionnaire. There were no signifi-
cant differences between the respondents and dropouts 
with respect to gender, functional disability, or pain, 
although the dropouts were slightly younger. For the 
DSS controls, the dropout rate at 6 months was <10%. 
No information was available in regard to the differences 
between the respondents and the dropouts.
Performance 
Figure 2 shows the calibration of the predictions. For 
the DSS control groups the predicted risks for sick 
leave were generally too high. Nevertheless, the mean 
predicted probability of 0.37 was only slightly higher 
than the overall observed sick leave prevalence (0.32). 
For the MDS cohort most of the plotted points were 
rather close to the 45-degree line, although three pre-
diction categories slightly overestimated the observed 
probabilities. Again, the mean predicted probability 
(0.39) was only slightly higher than the overall ob-
served sick leave prevalence (0.34). The discriminative 
ability (AUC) of the prediction rule was 0.66 (95% CI 
0.56–0.77) for the DSS controls groups and 0.71 (95% 
CI 0.63–0.80) for the MDS cohort. The results of the 
Monte Carlo simulation show that these estimates were 
close to the maximum attainable AUC (0.66 for the DSS 
controls and 0.70 for the MDS population), indicating 
that reductions in discrimination were not explained by 
poor calibration.
Table 3 shows the multivariate regression coef-
ficients when the rule was applied to the validation 
cohorts. Shoulder pain was a strong predictor of sick 
leave in the DSS control groups and in the MDS cohort. 
In the MDS cohort, sick leave in the 2 months preceding 
the baseline examination also showed a strong relation 
to sick leave during the follow-up. The category “0–1 
weeks” showed a remarkable negative association with 
outcome among the DSS controls. A similar opposite 
association was found for the category “4–6 points, 
shoulder pain” in the MDS cohort. 
Discussion
The performance of the prediction rule for sick leave due 
to shoulder pain in the DSS control groups showed an 
unstable calibration and a slightly decreased discrimi-
native ability (AUC of 0.66, compared with an AUC 
of 0.70 in the derivation cohort). The prediction rule 
calibrated better for the MDS population and showed a 
stable discriminative ability (AUC 0.71). 
The validation of a prediction rule is preferably 
started with populations that are very similar to the 
derivation cohort. In the next step, the rule is tested 
in populations that show more differences from the 
Figure 2. Calibration plots showing the observed frequencies versus 
the predicted probabilities for sick leave due to shoulder pain during 
the 6 months following the first consultation in primary care, for the 
controls of the Dutch shoulder study (DSS) (N=103) and a cohort of 
the musculoskeletal disorder study (MDS) (N=176). The patients were 
grouped into quintiles according to their predicted probability of sick leave 
due to shoulder pain according to the prediction rules. The prevalence 
of the end point within each quintile represents the observed individual 
probability.
Figure 2 Calibration plots showing the observed frequencies versus the predicted probabilities for 
shoulder pain related sick leave during 6 months following first consultation in primary care, for the 
DSS-controls (n=103) and the BAS cohort (n=176). Patients were grouped into quintiles according to their 
predicted probability of shoulder pain related sick leave according to the prediction rules. The prevalence of the 
endpoint within each quintiles represents the observed individual probability. 
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derivation cohort in terms of, for example, baseline 
characteristics or setting (13). The DSS was designed 
specifically to design and validate a clinical prediction 
rule for shoulder pain. The patients in both the deriva-
tion and validation cohorts (DSS control groups) were 
recruited by the same group of general practitioners, 
and they received similar treatment. The measurements 
were exactly the same and were carried out by the same 
research teams. This was an optimal setting in which 
to start testing the generalizability of the prediction 
rule. Although there was considerable similarity in the 
sampling frame and data collection between the DSS 
controls and the MDS participants, a different group of 
general practitioners participated in the MDS, the treat-
ment may have been somewhat different, and the data 
collection showed some differences. The MDS cohort 
was therefore a good cohort for use in the second step 
of the validation process. At the time of our study, no 
other good cohorts were available.
Patients that originate from clinical trials usually 
form a more selective population than patients partici-
pating in observational studies. Although the trials in the 
DSS used fairly broad selection criteria, this difference 
may have influenced the performances of the prediction 
rule with respect to the DSS controls. For example, the 
DSS controls included more patients with a long symp-
tom duration, which is an important prognostic factor. 
In addition, it may be possible that the patients who 
participated in the trials had different characteristics that 
were not measured in our study, for example, regarding 
treatment expectations or preferences.
Finally, the unstable calibration with the DSS control 
groups may also have partly been a result of the small 
numbers (N=103) in this validation cohort. Other stud-
ies have also shown that the calibration of prediction 
rules can be unstable when applied to a small popula-
tion (24). Table 3 shows large differences between the 
regression coefficients in the derivation cohort and the 
DSS controls. Shoulder pain was the only predictor 
among the DSS controls with a large and significant 
regression coefficient. The decreased AUC of 0.66 was 
confirmed by an equal maximum attainable AUC. This 
decreased discriminative ability may have been a result 
of differences in the baseline characteristics between the 
derivation and this validation cohort. 
In the MDS cohort, shoulder pain and sick leave at 
baseline in the preceding 2 months showed substantial 
and significant regression coefficients (table 3). This 
phenomenon, combined with higher regression coef-
ficients for strain or overuse due to usual activities and 
concomitant psychological complaints in the MDS 
cohort in comparison with the DSS controls, may have 
resulted in a better performance of the prediction rule 
for the MDS cohort. The substantial baseline differences 
between the derivation cohort and the MDS, in regard 
to factors that were not included in the prediction rule 
(gender, strain or overuse due to unusual activities, and 
concomitant musculoskeletal pain), did not seem to alter 
the performance. The maximum attainable AUC of 0.70 
in the MDS cohort strengthens our findings of adequate 
discriminative ability in this cohort. 
 We developed a rule to predict sick leave due to 
shoulder pain during the first 6 months after a first 
consultation. The elements of the prediction rule were 
derived from a questionnaire filled out by the patient. 
If the prediction rule is used in daily practice, it is the 
physician who will ask the questions and calculate the 
risk by using a score chart, or, in a more sophisticated 
way, enters the responses into a personal computer (PC) 
or personal digital assistant (PDA), which calculates the 
risk of sick leave over the next six months. Therefore, 
future research should also evaluate the methodological 
transportability of the prediction rule [ie, performance 
when data are collected with alternative methods (13) 
in a new sample of workers], and, perhaps most impor-
tantly, the clinical usefulness of the instrument should 
be established. In other words, can the prediction rule 
be helpful in making decisions in the management of 
patients with shoulder pain, for example, whether or not 
to consider additional diagnostic testing, start a certain 
treatment, or refer the patient to secondary care (15)?
Table 3. Multivariate regression coefficients for sick leave due 
to shoulder pain during 6 months after the first consultation in 
the validation in comparison with the coefficients obtained from 
the derivation cohort. The b values were derived from a multiple 
logistic regression analysis and were shrunk using bootstrapping 
techniques. The b values for the validation cohorts were computed 
by entering the four predictors of the rule simultaneously into a 
multiple logistic regression analysis, demonstrating the strength 
of the association between the predictors and sick leave in the 
validation cohorts in comparison with the derivation cohort. (DSS 
= Dutch shoulder study, MDS = musculoskeletal disorder study, b= 
regression coefficient, 95% CI = 95% confidence interval)
Predictor Derivation Validation
 DSS DSS controls MDS 
 (N=286) (N=103) (N=176)
 b 95% CI b 95% CI b 95% CI
Sick leave at baseline (in preceding 2 months)
 0–weeks a      
 0–1 week 0.53 –0.2–1.3 –0.34 –3.2–2.6 1.28 0.3–2.2
 >1 months 0.77 0.0–1.5 0.14 –2.9–3.1 2.66 1.5–3.7
Shoulder pain (0–10)      
 0–3 points a      
 4–6 points 0.50 –0.1–1.2 1.50 0.2–2.8 –0.12 –1.1–0.8
 7–10 points 0.65 –0.1–1.4 2.22 1.0–3.5 1.13 0.1–2.1
Strain or overuse,  
usual activities (yes, no) 0.68 0.1–1.3 0.11 –0.9–1.1 0.38 –0.4–1.2
Concomitant psycholog- 
ical complaints (yes, no) 1.38 0.4–2.4 0.33 –1.4–2.1 0.73 –0.3–1.7
a Reference category. 
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In conclusion, the prediction rule for sick leave due 
to shoulder pain during the first 6 months after a first 
consultation showed disappointing generalizability for 
the DSS controls but adequate generalizability for the 
MDS observational cohort. 
To enhance the performance of prediction rules in the 
future, rules should be updated and amended when new 
and larger cohorts become available. Validation should 
preferably be carried out prospectively, and—when sick 
leave is being predicted—in an occupational setting. 
Alternatively, separate models can be designed for pa-
tients with either acute or chronic shoulder problems, as 
different factors may be important in predicting outcome 
in these different patient groups. This step may further 
enhance the predictive performance of prediction rules 
for shoulder pain. 
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